Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. · 2010
Read Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor by Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011208.txt.
Description
Kachhap, Rosmus, Collis and colleagues studied prostate cancer drugs in PLOS ONE in 2010. A class of drugs loosens packed DNA, changing which genes are active. The team found these drugs also switch off genes that repair broken DNA by copying from a matching strand.
The shutdown ran through a single gene control factor. Turning off repair leaves cancer cells less able to survive DNA damage. That gives a clear logic for pairing these drugs with DNA damaging treatments. Such pairs could hit prostate tumors harder than either drug alone, a strategy now open to testing.
Catalog record
| CREATOR | Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011208